In different NAFLD-HCC mouse models, removing CD8+ T cells caused opposite effects on HCC progression (Shalapour et al., 2017; Pfister et al., 2021; Wolf et al., 2014). This evidence concerns the gene CD8A and metabolic dysfunction-associated steatotic liver disease.